APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anthropomorphic Test Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anthropomorphic Test Device Market Outlook and Growth Opportunities 2026

20 December 2025199 pages

Choose your research edition.

Industry ResearchAnthropomorphic Test Device Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Anthropomorphic Test Device Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Anthropomorphic Test Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anthropomorphic Test Device Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anthropomorphic Test Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Anthropomorphic Test Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anthropomorphic Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anthropomorphic Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anthropomorphic Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anthropomorphic Test Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anthropomorphic Test Device market include Cellbond, Dynamic Research, Humanetics and KYOWA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anthropomorphic Test Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anthropomorphic Test Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anthropomorphic Test Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anthropomorphic Test Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Anthropomorphic Test Device Segment by Company

Cellbond

Dynamic Research

Humanetics

KYOWA

Anthropomorphic Test Device Segment by Type

Child Dummy

Male Dummy

Female Dummy

Anthropomorphic Test Device Segment by Application

Automotive Crash Test

Aerospace Test

Others

Anthropomorphic Test Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anthropomorphic Test Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anthropomorphic Test Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anthropomorphic Test Device significant trends, drivers, influence factors in global and regions.

6. To analyze Anthropomorphic Test Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthropomorphic Test Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anthropomorphic Test Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthropomorphic Test Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anthropomorphic Test Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anthropomorphic Test Device industry.

Chapter 3: Detailed analysis of Anthropomorphic Test Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anthropomorphic Test Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anthropomorphic Test Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anthropomorphic Test Device Industry Trends Table 2. Anthropomorphic Test Device Industry Drivers Table 3. Anthropomorphic Test Device Industry Opportunities and Challenges Table 4. Anthropomorphic Test Device Industry Restraints Table 5. Global Anthropomorphic Test Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anthropomorphic Test Device Revenue Share by Company (2021-2026) Table 7. Global Anthropomorphic Test Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Anthropomorphic Test Device Sales Volume Share by Company (2021-2026) Table 9. Global Anthropomorphic Test Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Anthropomorphic Test Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anthropomorphic Test Device Key Company Manufacturing Base & Headquarters Table 12. Global Anthropomorphic Test Device Company, Product Type & Application Table 13. Global Anthropomorphic Test Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anthropomorphic Test Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Child Dummy Table 18. Significant Companies of Male Dummy Table 19. Significant Companies of Female Dummy Table 20. Global Anthropomorphic Test Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anthropomorphic Test Device Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Anthropomorphic Test Device Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Anthropomorphic Test Device Sales Volume Share by Type (2021-2026) Table 24. Global Anthropomorphic Test Device Sales Volume Share by Type (2027-2032) Table 25. Global Anthropomorphic Test Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anthropomorphic Test Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Anthropomorphic Test Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Anthropomorphic Test Device Sales Value Share by Type (2021-2026) Table 29. Global Anthropomorphic Test Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Automotive Crash Test Table 31. Significant Companies of Aerospace Test Table 32. Significant Companies of Others Table 33. Global Anthropomorphic Test Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Anthropomorphic Test Device Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Anthropomorphic Test Device Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Anthropomorphic Test Device Sales Volume Share by Application (2021-2026) Table 37. Global Anthropomorphic Test Device Sales Volume Share by Application (2027-2032) Table 38. Global Anthropomorphic Test Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Anthropomorphic Test Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Anthropomorphic Test Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Anthropomorphic Test Device Sales Value Share by Application (2021-2026) Table 42. Global Anthropomorphic Test Device Sales Value Share by Application (2027-2032) Table 43. Global Anthropomorphic Test Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Anthropomorphic Test Device Sales by Region (2021-2026) & (K Units) Table 45. Global Anthropomorphic Test Device Sales Market Share by Region (2021-2026) Table 46. Global Anthropomorphic Test Device Sales by Region (2027-2032) & (K Units) Table 47. Global Anthropomorphic Test Device Sales Market Share by Region (2027-2032) Table 48. Global Anthropomorphic Test Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Anthropomorphic Test Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Anthropomorphic Test Device Sales Value Share by Region (2021-2026) Table 51. Global Anthropomorphic Test Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Anthropomorphic Test Device Sales Value Share by Region (2027-2032) Table 53. Global Anthropomorphic Test Device Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Anthropomorphic Test Device Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Anthropomorphic Test Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Anthropomorphic Test Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Anthropomorphic Test Device Sales by Country (2021-2026) & (K Units) Table 58. Global Anthropomorphic Test Device Sales Market Share by Country (2021-2026) Table 59. Global Anthropomorphic Test Device Sales by Country (2027-2032) & (K Units) Table 60. Global Anthropomorphic Test Device Sales Market Share by Country (2027-2032) Table 61. Global Anthropomorphic Test Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Anthropomorphic Test Device Sales Value Market Share by Country (2021-2026) Table 63. Global Anthropomorphic Test Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Anthropomorphic Test Device Sales Value Market Share by Country (2027-2032) Table 65. Cellbond Company Information Table 66. Cellbond Business Overview Table 67. Cellbond Anthropomorphic Test Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Cellbond Anthropomorphic Test Device Product Portfolio Table 69. Cellbond Recent Development Table 70. Dynamic Research Company Information Table 71. Dynamic Research Business Overview Table 72. Dynamic Research Anthropomorphic Test Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Dynamic Research Anthropomorphic Test Device Product Portfolio Table 74. Dynamic Research Recent Development Table 75. Humanetics Company Information Table 76. Humanetics Business Overview Table 77. Humanetics Anthropomorphic Test Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Humanetics Anthropomorphic Test Device Product Portfolio Table 79. Humanetics Recent Development Table 80. KYOWA Company Information Table 81. KYOWA Business Overview Table 82. KYOWA Anthropomorphic Test Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. KYOWA Anthropomorphic Test Device Product Portfolio Table 84. KYOWA Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Anthropomorphic Test Device Distributors List Table 88. Anthropomorphic Test Device Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Anthropomorphic Test Device Product Image Figure 2. Global Anthropomorphic Test Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anthropomorphic Test Device Sales (2021-2032) & (K Units) Figure 5. Global Anthropomorphic Test Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Anthropomorphic Test Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Child Dummy Image Figure 10. Male Dummy Image Figure 11. Female Dummy Image Figure 12. Global Anthropomorphic Test Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Anthropomorphic Test Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Anthropomorphic Test Device Sales Volume Share by Type (2021-2032) Figure 15. Global Anthropomorphic Test Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Anthropomorphic Test Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Anthropomorphic Test Device Sales Value Share by Type (2021-2032) Figure 18. Automotive Crash Test Image Figure 19. Aerospace Test Image Figure 20. Others Image Figure 21. Global Anthropomorphic Test Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anthropomorphic Test Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Anthropomorphic Test Device Sales Volume Share by Application (2021-2032) Figure 24. Global Anthropomorphic Test Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Anthropomorphic Test Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Anthropomorphic Test Device Sales Value Share by Application (2021-2032) Figure 27. Global Anthropomorphic Test Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Anthropomorphic Test Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Anthropomorphic Test Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Anthropomorphic Test Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Anthropomorphic Test Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Anthropomorphic Test Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Anthropomorphic Test Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Anthropomorphic Test Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Anthropomorphic Test Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Anthropomorphic Test Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Anthropomorphic Test Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Anthropomorphic Test Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Anthropomorphic Test Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Child Dummy
  • Male Dummy
  • Female Dummy
Applications
  • Automotive Crash Test
  • Aerospace Test
  • Others
Companies covered
  • Cellbond
  • Dynamic Research
  • Humanetics
  • KYOWA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anthropomorphic Test Device Sales Value (2021-2032)
  4. 1.2.2 Global Anthropomorphic Test Device Sales Volume (2021-2032)
  5. 1.2.3 Global Anthropomorphic Test Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anthropomorphic Test Device Market Dynamics
  1. 2.1 Anthropomorphic Test Device Industry Trends
  2. 2.2 Anthropomorphic Test Device Industry Drivers
  3. 2.3 Anthropomorphic Test Device Industry Opportunities and Challenges
  4. 2.4 Anthropomorphic Test Device Industry Restraints
3 Anthropomorphic Test Device Market by Company
  1. 3.1 Global Anthropomorphic Test Device Company Revenue Ranking in 2025
  2. 3.2 Global Anthropomorphic Test Device Revenue by Company (2021-2026)
  3. 3.3 Global Anthropomorphic Test Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Anthropomorphic Test Device Average Price by Company (2021-2026)
  5. 3.5 Global Anthropomorphic Test Device Company Ranking (2024-2026)
  6. 3.6 Global Anthropomorphic Test Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Anthropomorphic Test Device Company Product Type and Application
  8. 3.8 Global Anthropomorphic Test Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anthropomorphic Test Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anthropomorphic Test Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anthropomorphic Test Device Market by Type
  1. 4.1 Anthropomorphic Test Device Type Introduction
  2. 4.1.1 Child Dummy
  3. 4.1.2 Male Dummy
  4. 4.1.3 Female Dummy
  5. 4.2 Global Anthropomorphic Test Device Sales Volume by Type
  6. 4.2.1 Global Anthropomorphic Test Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anthropomorphic Test Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Anthropomorphic Test Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Anthropomorphic Test Device Sales Value by Type
  10. 4.3.1 Global Anthropomorphic Test Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anthropomorphic Test Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Anthropomorphic Test Device Sales Value Share by Type (2021-2032)
5 Anthropomorphic Test Device Market by Application
  1. 5.1 Anthropomorphic Test Device Application Introduction
  2. 5.1.1 Automotive Crash Test
  3. 5.1.2 Aerospace Test
  4. 5.1.3 Others
  5. 5.2 Global Anthropomorphic Test Device Sales Volume by Application
  6. 5.2.1 Global Anthropomorphic Test Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anthropomorphic Test Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Anthropomorphic Test Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Anthropomorphic Test Device Sales Value by Application
  10. 5.3.1 Global Anthropomorphic Test Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Anthropomorphic Test Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Anthropomorphic Test Device Sales Value Share by Application (2021-2032)
6 Anthropomorphic Test Device Regional Sales and Value Analysis
  1. 6.1 Global Anthropomorphic Test Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anthropomorphic Test Device Sales by Region (2021-2032)
  3. 6.2.1 Global Anthropomorphic Test Device Sales by Region: 2021-2026
  4. 6.2.2 Global Anthropomorphic Test Device Sales by Region (2027-2032)
  5. 6.3 Global Anthropomorphic Test Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anthropomorphic Test Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anthropomorphic Test Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anthropomorphic Test Device Sales Value by Region (2027-2032)
  9. 6.5 Global Anthropomorphic Test Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anthropomorphic Test Device Sales Value (2021-2032)
  12. 6.6.2 North America Anthropomorphic Test Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anthropomorphic Test Device Sales Value (2021-2032)
  15. 6.7.2 Europe Anthropomorphic Test Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anthropomorphic Test Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anthropomorphic Test Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anthropomorphic Test Device Sales Value (2021-2032)
  21. 6.9.2 South America Anthropomorphic Test Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anthropomorphic Test Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anthropomorphic Test Device Sales Value Share by Country, 2025 VS 2032
7 Anthropomorphic Test Device Country-level Sales and Value Analysis
  1. 7.1 Global Anthropomorphic Test Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anthropomorphic Test Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anthropomorphic Test Device Sales by Country (2021-2032)
  4. 7.3.1 Global Anthropomorphic Test Device Sales by Country (2021-2026)
  5. 7.3.2 Global Anthropomorphic Test Device Sales by Country (2027-2032)
  6. 7.4 Global Anthropomorphic Test Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anthropomorphic Test Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anthropomorphic Test Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anthropomorphic Test Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anthropomorphic Test Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anthropomorphic Test Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cellbond
  2. 8.1.1 Cellbond Company Information
  3. 8.1.2 Cellbond Business Overview
  4. 8.1.3 Cellbond Anthropomorphic Test Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cellbond Anthropomorphic Test Device Product Portfolio
  6. 8.1.5 Cellbond Recent Developments
  7. 8.2 Dynamic Research
  8. 8.2.1 Dynamic Research Company Information
  9. 8.2.2 Dynamic Research Business Overview
  10. 8.2.3 Dynamic Research Anthropomorphic Test Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dynamic Research Anthropomorphic Test Device Product Portfolio
  12. 8.2.5 Dynamic Research Recent Developments
  13. 8.3 Humanetics
  14. 8.3.1 Humanetics Company Information
  15. 8.3.2 Humanetics Business Overview
  16. 8.3.3 Humanetics Anthropomorphic Test Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Humanetics Anthropomorphic Test Device Product Portfolio
  18. 8.3.5 Humanetics Recent Developments
  19. 8.4 KYOWA
  20. 8.4.1 KYOWA Company Information
  21. 8.4.2 KYOWA Business Overview
  22. 8.4.3 KYOWA Anthropomorphic Test Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 KYOWA Anthropomorphic Test Device Product Portfolio
  24. 8.4.5 KYOWA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anthropomorphic Test Device Value Chain Analysis
  2. 9.1.1 Anthropomorphic Test Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anthropomorphic Test Device Sales Mode & Process
  6. 9.2 Anthropomorphic Test Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anthropomorphic Test Device Distributors
  9. 9.2.3 Anthropomorphic Test Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst